NCT04921748

Brief Summary

The sequence effect (SE), defined as a reduction in amplitude of repetitive movements, is a common clinical feature of Parkinson's disease (PD), being a major contributor to freezing of gait (FOG). During walking, SE manifests as a step-by-step reduction in step length when approaching a turn or gait destination (dSE). The investigators studied the effect of a 4-week rehabilitation program on the destination sequence effect in patients affected by Parkinson's disease with and without Freezing of Gait. All subjects were evaluated with inertial gait analysis for dSE recording.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2021

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 4, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 10, 2021

Completed
Last Updated

June 15, 2021

Status Verified

June 1, 2021

Enrollment Period

1.5 years

First QC Date

June 4, 2021

Last Update Submit

June 10, 2021

Conditions

Keywords

Movement disordersGait analysisHypokinesiaBasal gangliaFunctional indipendence

Outcome Measures

Primary Outcomes (1)

  • Destination sequence effect (dSE) modifications

    Using an inertial gait analysis we will explore the modifications of destination sequence effect in PD patients with and without freezing of gait treated with a 4-week in-hospital rehabilitation program

    Change from baseline (T0) to four weeks (T1)

Secondary Outcomes (13)

  • Between-group comparison of dSE

    Baseline (T0)

  • Gait hypokinesia modifications

    Change from baseline (T0) to four weeks (T1)

  • Speed modifications

    Change from baseline (T0) to four weeks (T1)

  • Cadence modifications

    Change from baseline (T0) to four weeks (T1)

  • Stride duration modifications

    Change from baseline (T0) to four weeks (T1)

  • +8 more secondary outcomes

Study Arms (2)

PD+FOG group

Patients affected by Parkinson's Disease with freezing of gait (PD+FOG group)

Procedure: Neurorehabilitation

PD-FOG group

Patients affected by Parkinson's Disease without freezing of gait (PD+FOG group)

Procedure: Neurorehabilitation

Interventions

All patients will be treated with an in-hospital rehabilitation program focused on the rehabilitation of gait disorder in PD with 90-minute daily sessions, 6 days a week (Monday through Saturday) for four weeks. The rehabilitation treatment includes passive, active-assisted, and active exercises, isotonic and isometric exercises for the major muscles of the limbs and trunk, cardiovascular warm-up exercises, muscle stretching exercises for functional purposes, balance training exercises, specific motor exercise for hypokinesia, and 45 minutes of overground gait training delivered without devices or cueing The rehabilitation program is the same in PD patients with and without FOG.

Also known as: Rehabilitation, Physical therapy
PD+FOG groupPD-FOG group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients affected by Idiopathic Parkinson's disease with and without freezing of gait to be consecutively enroll among those attending the Neurorehabilitation Department of the IRCCS Mondino Foundation (Pavia, Italy)

You may qualify if:

  • Idiopathic Parkinson's disease
  • Hoehn and Yahr stage between I and IV
  • Mini-Mental State Examination score above 24.

You may not qualify if:

  • Major psychiatric or other neurological conditions,
  • Rheumatological diseases
  • Ophthalmic diseases
  • Orthopedic diseases
  • Ongoing or previous treatment with neuroleptic drugs
  • Patients with deep brain stimulation
  • Any change in dose or regimen of the anti-parkinsonian therapy in the last month before enrolment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Mondino Foundation

Pavia, 27100, Italy

Location

Related Publications (2)

  • Kang SY, Wasaka T, Shamim EA, Auh S, Ueki Y, Lopez GJ, Kida T, Jin SH, Dang N, Hallett M. Characteristics of the sequence effect in Parkinson's disease. Mov Disord. 2010 Oct 15;25(13):2148-55. doi: 10.1002/mds.23251.

    PMID: 20669182BACKGROUND
  • Cao SS, Yuan XZ, Wang SH, Taximaimaiti R, Wang XP. Transverse Strips Instead of Wearable Laser Lights Alleviate the Sequence Effect Toward a Destination in Parkinson's Disease Patients With Freezing of Gait. Front Neurol. 2020 Aug 12;11:838. doi: 10.3389/fneur.2020.00838. eCollection 2020.

    PMID: 32903360BACKGROUND

MeSH Terms

Conditions

Parkinson DiseaseMovement DisordersHypokinesia

Interventions

Neurological RehabilitationRehabilitationPhysical Therapy Modalities

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesSynucleinopathiesNeurodegenerative DiseasesDyskinesiasNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Roberto De Icco, MD

    IRCCS Mondino Foundation, Pavia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2021

First Posted

June 10, 2021

Study Start

August 1, 2019

Primary Completion

January 31, 2021

Study Completion

February 28, 2021

Last Updated

June 15, 2021

Record last verified: 2021-06

Locations